NSE · PGHL
Procter & Gamble Health Limited
₹5,932.00
+0.14%
Market Cap
9,847.12 Cr
P/E Ratio
30.12
P/B Ratio
18.77
ROE
62.32%
ROCE
76.81%
Dividend Yield
2.61%
52W High
₹6,739.00
52W Low
₹5,290.00
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 363.71 Cr | 370.45 Cr | 373.86 Cr | 324.92 Cr |
| Net Profit | 96.15 Cr | 94.60 Cr | 77.59 Cr | 88.54 Cr |
| EPS | 57.92 | 56.99 | 46.74 | 53.34 |
| Operating Profit | 97.46 Cr | 133.42 Cr | 108.92 Cr | 119.14 Cr |
Shareholding pattern
Promoter
51.82%
Public
48.18%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Feb 2026 | Dividend | Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share |
| 22 Aug 2025 | Dividend | Dividend - Rs 45 Per Share |
| 21 Feb 2025 | Dividend | Interim Dividend - Rs 80 Per Share |
| 28 Nov 2024 | Dividend | Annual General Meeting/Dividend - Rs 60 Per Share |
| 14 Feb 2024 | Dividend | Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.